Patents by Inventor Joerg Benz

Joerg Benz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190382489
    Abstract: The present invention relates to anti-PD1 antibodies and methods of using the same.
    Type: Application
    Filed: December 18, 2018
    Publication date: December 19, 2019
    Applicant: Hoffmann-La Roche Inc.
    Inventors: JOERG BENZ, LAURA CODARRI DEAK, STEFAN DENGL, SEBASTIAN FENN, JENS FISCHER, GUY GEORGES, CHRISTIAN KLEIN, VIKTOR LEVITSKI, VALERIA LIFKE, OLIVER PLOETTNER, STEFAN SEEBER, BARBARA WEISER, ILDIKO WUENSCHE, ADRIAN ZWICK
  • Patent number: 10465000
    Abstract: The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: November 5, 2019
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Fiona Grueninger, Guy Georges, Olaf Mundigl, Michael Schraeml, Bernd Bohrmann, Ulrich Goepfert, Joerg Benz, Hubert Kettenberger
  • Publication number: 20190248916
    Abstract: The present invention generally relates to antibodies that bind to HLA-A2/WT1, including bispecific antigen binding molecules e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
    Type: Application
    Filed: December 20, 2018
    Publication date: August 15, 2019
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Joerg Benz, Christian Klein, Stefan Klostermann, Ekkehard Moessner, Johannes Sam, Pablo Umaña, Lydia Jasmin Hanisch, Alexander Bujotzek, Wei Xu
  • Patent number: 10308710
    Abstract: The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: June 4, 2019
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Fiona Grueninger, Guy Georges, Olaf Mundigl, Michael Schraeml, Bernd Bohrmann, Ulrich Goepfert, Joerg Benz, Hubert Kettenberger
  • Publication number: 20170247454
    Abstract: The present invention relates to anti-PD1 antibodies and methods of using the same.
    Type: Application
    Filed: September 29, 2016
    Publication date: August 31, 2017
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Joerg Benz, Laura Codarri Deak, Stefan Dengl, Sebastian Fenn, Jens Fischer, Guy Georges, Christian Klein, Viktor Levitski, Valeria Lifke, Oliver Ploettner, Stefan Seeber, Barbara Weiser, Ildiko Wuensche, Adrian Zwick
  • Publication number: 20170129949
    Abstract: The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.
    Type: Application
    Filed: December 22, 2016
    Publication date: May 11, 2017
    Inventors: Fiona Grueninger, Guy Georges, Olaf Mundigl, Michael Schraeml, Bernd Bohrmann, Ulrich Goepfert, Joerg Benz, Hubert Kettenberger
  • Patent number: 9562091
    Abstract: The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: February 7, 2017
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Fiona Grueninger, Guy Georges, Olaf Mundigl, Michael Schraeml, Bernd Bohrmann, Ulrich Goepfert, Joerg Benz, Hubert Kettenberger
  • Publication number: 20150258209
    Abstract: Herein is reported a conjugate comprising an antigen and an antibody that specifically binds to the antigen wherein a covalent bond is formed between the antigen and an amino acid residue in the CDR2 of the antibody, an antibody comprising a cysteine residue at amino acid position 53 (according to Kabat) in the heavy chain CDR2 and uses thereof.
    Type: Application
    Filed: December 19, 2014
    Publication date: September 17, 2015
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: JOERG BENZ, ULRICH BRINKMANN, STEFAN DENGL, SEBASTIAN DZIADEK, GUY GEORGES, MICHAEL GROTE, ALEXANDER HAAS, EIKE HOFFMANN
  • Patent number: 9085760
    Abstract: The present invention relates to a polypeptide binding to a chymase (EC 3.4.21.
    Type: Grant
    Filed: April 24, 2012
    Date of Patent: July 21, 2015
    Assignee: COVAGEN AG
    Inventors: Simon Brack, Sarah Batey, Dragan Grabulovski, Julian Bertschinger, Daniel Schlatter, Jörg Benz, David Banner, Michael Hennig
  • Publication number: 20150175685
    Abstract: The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.
    Type: Application
    Filed: December 18, 2014
    Publication date: June 25, 2015
    Inventors: Fiona Grueninger, Guy Georges, Olaf Mundigl, Michael Schraeml, Bernd Bohrmann, Ulrich Goepfert, Joerg Benz, Hubert Kettenberger
  • Publication number: 20140162936
    Abstract: The present invention relates to a polypeptide binding to a chymase (EC 3, 4, 21,39), wherein the polypeptide comprises or consists of an amino acid sequence selected from the group consisting of: (a) GVTLFVALYDY(X1)A(X2)(X3)(X4)(X5) (X6)LSFHKGEKFQIL(X7 (X8)(X9)(X10) (X11)(X12)G(X13)(X14)WEARSLTTGETGYIPSNYVAPVDSIQ (SEQ ID NO: 1), wherein (X1) is R, N, Q, E, K, H, S, T, C, or D; (X2) is E, T, D, Q, L, P, A, S, C, M, N, E, G, A, V or I; (X3) is R, T, H, N, K, S, C, N or Q; (X4) is S, W, T, C, N, Q, For Y; (X5) is T, H, L, F, C, S, M, N, Q, R, K, G, A, V, I, P, Y or W; (X6) is D, Q, H, E, S, T, C, N, R or K; (X7) is D, N, R, E, Q, S, T, C, K or D; (X8) is M, W, G, F, A, S, T, C, S, N, Q, Y, V, L, I or P; (X9) is T, H, S, D, C, N, Q, R, K, E or absent; (X10) is V, T, Q, G, A, L, I, P, S, C, M, N or absent; (X11) is P, A, D, G, K, V, L, I, E, R, M, H or absent; (X12) is N, V, P, I, E, T, S, A, G, L, C, M, Q or D; (X13) is D, E, T, P, G, A, V, L, I, S, C, M, N or Q, and (X14) is W, Y, L, G, A, V, I, P, M, or F; (b)
    Type: Application
    Filed: April 24, 2012
    Publication date: June 12, 2014
    Applicant: COVAGEN AG
    Inventors: Simon Brack, Sarah Batey, Dragan Grabulovski, Julian Bertschinger, Daniel Schlatter, Jörg Benz, David Banner, Michael Hennig
  • Patent number: 8309340
    Abstract: The present invention provides apo crystals and co-crystals of insulin-degrading enzyme (IDE) and their uses in drug development.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: November 13, 2012
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Joerg Benz, Dominique Burger, Martine Stihle, Ralf Thoma
  • Patent number: 8033573
    Abstract: A rollover protection system for motor vehicles with a roll bar, which can be moved by a drive unit from a position of rest to a protection position, is secured in the protection position by a locking device and prevented from retracting, and is fixed in the position of rest by a holding device, wherein the holding device has a movably arranged catch element which can be disengaged abruptly by a pyrotechnic actuator. For such cases in which the catch element can move beyond the release point and there is a danger of a rebounding, because a path-limiting stop is present, a structural part is provided that prevents a return movement of the catch element into the holding position.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: October 11, 2011
    Assignee: Ise Automotive GmbH
    Inventors: Gürkan Beki, Stephan Berges, Michael Nass, Dietmar Wacker, Jörg Benz
  • Publication number: 20110060580
    Abstract: The present invention relates to co-crystals of Liver X receptor beta ligand binding domain (LXR?-LBD) with agonists and to the three-dimensional X-ray crystal structures derived thereof.
    Type: Application
    Filed: March 10, 2009
    Publication date: March 10, 2011
    Inventors: Joerg Benz, Bernard Gsell, Martine Stihle, Ralf Thoma, Matthew Wright
  • Publication number: 20100323427
    Abstract: The present invention provides apo crystals and co-crystals of insulin-degrading enzyme (IDE) and their uses in drug development.
    Type: Application
    Filed: December 22, 2008
    Publication date: December 23, 2010
    Inventors: Joerg Benz, Dominique Burger, Martine Stihle, Ralf Thoma
  • Publication number: 20070048853
    Abstract: The present invention provides crystals of carnitine palmitoyltransferase (CPT) and co-crystals of CPT with an inhibitor compounds that allow screening for novel inhibitors of CPT-2 by determining the structure of co-crystals based on the coordinates of the crystals disclosed herein.
    Type: Application
    Filed: August 21, 2006
    Publication date: March 1, 2007
    Inventors: Joerg Benz, Bernard Gsell, Michael Hennig, Arne Rufer, Martine Stihle, Ralf Thoma
  • Patent number: 5945750
    Abstract: Stepping motor comprising a rotor (4) and two, one above the other and with respect to each other angularly offset, stators (2) which are comprised of coils (30) and stator plates (20), wherein the stator plates (20) respectively have a planer U-shaped form with two essentially parallel extending arms (22, 25), the end of arms (22, 25) each exhibits on the inside for the formation of a polar pair an arch shaped recess (23, 26) such that the rotor (4) extending therebetween, in top view, is encompassed along its circumferential segment corresponding to the contour without, however, making contact.
    Type: Grant
    Filed: February 12, 1996
    Date of Patent: August 31, 1999
    Assignee: TRW Fahrzeugelektrik Gmbh & Co. KG
    Inventors: Roland Sauter, Joerg Benz